Score and Assessment Systems |
Author: | Knaus WA, Wagner DP, Draper EA, et al: The APACHE III prognostic system, risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-1636 |
Address: | Dr Knaus, 2300 K Street, NW, Washington DC 20037 |
Original Work: | Original |
Coypright: |
unknown |
Trademark: |
unknown |
Explanation: | |
HL7 v2.x datatype: | |
HL7 V3 datatype: | |
Specialities: |
Intensive Care / Intensivmedizin
|
Interpretation must be defined!
Comp. | Decription | Bezeichnung | Code System: Codes/ Score Value |
Details / Score Range |
/ Units |
HL7 DT v2 + V3 | / Snomed CT |
---|---|---|---|---|---|---|---|
1 | Body temperature |
Körpertemperatur | |||||
36- 39,9 | 0 | - | NM + INT | ||||
35- 35,9 | 2 | - | NM + INT | ||||
=40 | 4 | - | NM + INT | ||||
34- 34,9 | 8 | - | NM + INT | ||||
33,5- 33,9 | 13 | - | NM + INT | ||||
33-33,4 | 16 | - | NM + INT | ||||
=32,9 | 20 | - | NM + INT | ||||
2 | Intravascular mean |
mittlerer arterieller Blutdruck | |||||
80-99 | 0 | - | NM + INT | ||||
100-119 | 4 | - | NM + INT | ||||
70-79 | 6 | - | NM + INT | ||||
120-129 | 7 | - | NM + INT | ||||
130-139 | 9 | - | NM + INT | ||||
=140 | 10 | - | NM + INT | ||||
40- 59 | 15 | - | NM + INT | ||||
=39 | 23 | - | NM + INT | ||||
60-69 | - | NM + INT | |||||
3 | Heart rate |
Herzfrequenz | |||||
50-99 | 0 | - | NM + INT | ||||
100-109 | 1 | - | NM + INT | ||||
40- 49 | 5 | - | NM + INT | ||||
120- 139 | 7 | - | NM + INT | ||||
=39 | 8 | - | NM + INT | ||||
140- 154 | 13 | - | NM + INT | ||||
=155 | 17 | - | NM + INT | ||||
110- 119 | - | NM + INT | |||||
4 | Respiratory Rate |
Atemfrequenz | |||||
14-24 | 0 | - | NM + INT | ||||
25- 34 | 6 | - | NM + INT | ||||
12-13 | 7 | - | NM + INT | ||||
6-11 | 8 | - | NM + INT | ||||
35-39 | 9 | - | NM + INT | ||||
40-49 | 11 | - | NM + INT | ||||
=5 | 17 | - | NM + INT | ||||
=50 | 18 | - | NM + INT | ||||
for patient on mechanical ventilation | für beatmete Patienten | 8 | - | NM + INT | |||
5 | Oxygen |
Sauerstoffpartialdruck | |||||
=80 | 0 | - | NM + INT | ||||
70-79 | 2 | - | NM + INT | ||||
50-69 | 5 | - | NM + INT | ||||
=49 | 15 | - | NM + INT | ||||
6 | Oxygen.alveolar-arterial |
arterio-alveoläre Sauerstoffdifferenz | |||||
<100 | 0 | - | NM + INT | ||||
100-249 | 7 | - | NM + INT | ||||
250- 349 | 9 | - | NM + INT | ||||
350-499 | 11 | - | NM + INT | ||||
=500 | 14 | - | NM + INT | ||||
only use for intubated patients with FiO2=0,5 | - | NM + INT | |||||
8 | Sodium |
Natrium | |||||
135- 154 mMol/L (mEq/L) | 0 | - | mMol/L | NM + INT | |||
120- 134 mMol/L (mEq/L) | 2 | - | mMol/L | NM + INT | |||
=119 mMol/L (mEq/L) | 3 | - | mMol/L | NM + INT | |||
= 155 mMol/L (mEq/L) | 4 | - | mMol/L | NM + INT | |||
10 | Creatinine |
Kreatinin | |||||
0,6- 1,4 | 0 | - | NM + INT | ||||
<0,6 | 2 | - | NM + INT | ||||
2- 3,4 | 3 | - | NM + INT | ||||
>3, 5 | 4 | - | NM + INT | ||||
1,5- 1,9 | - | NM + INT | |||||
11 | Hematocrit |
Hämatokrit | |||||
41-49 | 0 | - | NM + INT | ||||
=40,9 | 3 | - | NM + INT | ||||
=50 | 3 | - | NM + INT | ||||
12 | Leucocytes |
Leukozyten | |||||
3- 19,9 | 0 | - | NM + INT | ||||
20-24,9 | 1 | - | NM + INT | ||||
1,0- 2,9 | 5 | - | NM + INT | ||||
=1 | 19 | - | NM + INT | ||||
=25 | - | NM + INT | |||||
13 | Glucose |
Glukose | |||||
80-190 mg/dL | 0 | - | NM + INT | ||||
200- 349 mg/dL | 3 | - | NM + INT | ||||
=350 | 5 | - | NM + INT | ||||
40- 50 mg/dL | 9 | - | mg/dL | NM + INT | |||
= 30mg/dL | 8 | - | mg/dL | NM + INT | |||
3,4- 11,1mmol/dL | - | mmol/dL | NM + INT | ||||
11,2-19,3 mmol/dL | - | mmol/dL | NM + INT | ||||
=19,4 | - | NM + INT | |||||
2,2-3,3 mmol/dL | - | mmol/dL | NM + INT | ||||
=2,1mmol/dL | - | mmol/dL | NM + INT | ||||
14 | Urea nitrogen |
Harnstoff- Stickstoff | |||||
= 16,9 mg/dL | 0 | - | mg/dL | NM + INT | |||
17- 19 mg/dL | 2 | - | mg/dL | NM + INT | |||
20-39 mg/dL | 7 | - | mg/dL | NM + INT | |||
40- 79 mg/dL | 11 | - | mg/dL | NM + INT | |||
=80mg/dL | 12 | - | NM + INT | ||||
=6,1 mmol/L | - | NM + INT | |||||
6,2- 7,1 mmol/L | - | NM + INT | |||||
7,2-14,3 mmol/L | - | NM + INT | |||||
14,4- 28,5 mmol/L | - | NM + INT | |||||
=28,6 mmol/L | - | NM + INT | |||||
15 | Albumin |
Serumalbumin | |||||
2,5-4,4 g/dL | 0 | - | NM + INT | ||||
=4,5 g/dL | 4 | - | NM + INT | ||||
2,0-2,4 g/dL | 6 | - | NM + INT | ||||
=1,9g/dL | 11 | - | NM + INT | ||||
25-44 g/L | - | NM + INT | |||||
=45g/L | - | NM + INT | |||||
20-24 g/L | - | NM + INT | |||||
=19g/L | - | NM + INT | |||||
16 | Bilirubin |
Serumbilirubin | |||||
=34µmol/L | 0 | - | NM + INT | ||||
35-51 µmol/L | 5 | - | NM + INT | ||||
52-85 µmol/L | 6 | - | NM + INT | ||||
86- 136µmol/L | 8 | - | NM + INT | ||||
= 136µmol/L | 16 | - | NM + INT | ||||
=1,9 mg/dL | - | NM + INT | |||||
2-2,9 mg/dL | - | NM + INT | |||||
3- 4,9 mg/dL | - | NM + INT | |||||
5- 7,9mg/dL | - | NM + INT | |||||
=8mg/dL | - | NM + INT | |||||
17 | Urine output |
Urin Ausscheidung | |||||
2000-3999 mL/d | 0 | - | NM + INT | ||||
=4000 mL/d | 1 | - | NM + INT | ||||
1500-1999 mL/d | 4 | - | NM + INT | ||||
900-1499 mL/d | 5 | - | NM + INT | ||||
600-899 mL/d | 7 | - | NM + INT | ||||
400-599 mL/d | 8 | - | NM + INT | ||||
=399 mL/d | 15 | - | NM + INT | ||||
18 | acid- base disturbances
acid- base disturbances |
Säure- Basenhaushalt | |||||
19 | altered GCS |
||||||
20 | Age |
Alter | |||||
=44 | 0 | - | NM + INT | ||||
45- 59 | 5 | - | NM + INT | ||||
60- 64 | 11 | - | NM + INT | ||||
65- 69 | 13 | - | NM + INT | ||||
70-74 | 16 | - | NM + INT | ||||
75-84 | 17 | - | NM + INT | ||||
=85 | 24 | - | NM + INT | ||||
21 | Comorbid condition |
Begleiterkrankungen | |||||
Zirrhose | Cirrhosis | 4 | - | NM + INT | |||
Immunsuppression oder Leukämie/ multiples Myelom | Immunosupression or Leukemia/multiple myeloma | 10 | - | NM + INT | |||
metastasierendes Karzinom | metastatic cancer | 11 | - | NM + INT | |||
Lymphom | lymphoma | 13 | - | NM + INT | |||
Leberversagen | hepatic failure | 16 | - | NM + INT | |||
AIDS | AIDS | 23 | - | NM + INT | |||
excluded für elective surgery patients | - | NM + INT | |||||
TOTAL SCORE | Acute Physiology And Chronic Health Evaluation Score (III) |
LOINC: 9265-0 Snomed CT: 273259007 |
The primary purpose of the information provided above is to enhance interoperability. The primary focus lies on the assigned codes.
Therefore, no guarantee can be given whether the use of the score or assessment system is allowed or not.
It is highly recommended to check with the author directly.
We are aware that the presented information may be not enough in order to work with it.
The authors have done their best to ensure copyright and other jurisdictional requirements.